Adaptive Biotechnologies Corp 4

Francis Lo, Chief People Officer of Adaptive Biotechnologies Corp (ADPT), exercised 105,762 stock options and sold 105,762 common shares on 2026-07-15 under a Rule 10b5-1 plan.

On July 15, 2026, Francis Lo, Chief People Officer of Adaptive Biotechnologies Corp, exercised three tranches of stock options for a total of 105,762 shares of common stock at strike prices of $7.80, $12.14, and $8.46 per share and concurrently sold 105,762 shares at a weighted average price of $22.59 per share under a pre-established Rule 10b5-1 trading plan, resulting in net share ownership remaining substantial at 230,713 directly held shares plus 2,500 shares held indirectly by a spouse. The option exercises generated an approximate intrinsic value of about $1.24 million based on the spread between the sale price and the respective exercise prices, while the gross sale proceeds were roughly $2.39 million; after these transactions, Lo continues to hold a significant equity position in Adaptive Biotechnologies. The reported sale price reflects multiple trades executed between $22.49 and $22.78 per share, and the options exercised were fully vested at the time of exercise.

Filing Facts

CIK

1478320

Ticker

ADPT

Form

4

Source Type

fda

Accession

0001780660-26-000019

Alert Tier

6